Mass spectroscopy analysis of mutant polypeptides in biological samples
Cell Signaling Technology, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/300,212, filed Feb 1, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,036,756 | Mass Spectrometry Analysis Of Mutant Polypeptides In Biological Samples In force · High confidence UsedRemaining | Cell Signaling Technology, Inc. | In force | High confidence | ||
| US 10,670,606 | Mass Spectrometry Analysis of Mutant Polypeptides in Biological Samples In force · High confidence | Cell Signaling Technology, Inc. | In force | High confidence | ||
| US 9,453,845 | Mass spectroscopy analysis of mutant polypeptides in biological samples In force · High confidence | Cell Signaling Technology, Inc. | In force | High confidence | ||
| US 11,428,696 | Mass Spectrometry Analysis of Mutant Polypeptides in Biological Samples Lapsed Aug 30, 2026 on the fee record High confidence | Cell Signaling Technology | Lapsed Aug 30, 2026 on the fee record | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Cell Signaling Technology, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.